AC Immune S.A.

NASDAQ: ACIU · Real-Time Price · USD
2.10
0.05 (2.44%)
At close: Aug 20, 2025, 1:10 PM

AC Immune S.A. Income Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.31M 990K 1.14M 25.48M 687K n/a 14.8M n/a n/a n/a 1K 3.93M n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a 14.48M 17.14M 15.16M 14.64M 12.41M 13.68M 13.87M 15.14M 14.38M 15.69M 15.12M 20.12M 15.12M 13.71M 13.33M
Gross Profit
1.31M 990K 1.14M 25.48M -16.45M -15.16M 157K -12.41M -13.68M -13.87M -15.13M -10.45M -15.69M -15.12M -20.12M -15.12M -13.71M -13.33M
Operating Income
-19.39M -19.37M -18.62M 7.27M -20.96M -20.07M -3.54M -15.47M -17.05M -17.57M -18.7M -13.46M -19.86M -18.83M -22.79M -20.28M -18.69M -17.25M
Interest Income
458K 687K 889K 939K 739K 629K 291K 285K 259K 209K 59K 11K n/a n/a 2.06M 4.42M n/a n/a
Pretax Income
-21.19M -19.03M -15.79M 5.5M -22.76M -17.86M -4.74M -15.14M -16.83M -17.51M -18.75M -13.51M -19.64M -18.84M -21.27M -15.92M -19.07M -16.73M
Net Income
-21.19M -19.03M -15.8M 5.5M -22.76M -17.86M -4.74M -15.14M -16.83M -17.51M -18.75M -13.52M -19.64M -18.85M -21.28M -15.92M -19.07M -16.73M
Selling & General & Admin
3.9M 4.44M -1.84M 3.75M 4.55M 4.97M -676K 3.46M 3.68M 4.11M -2.25M 3.27M 4.37M 4.17M -4.11M 5.42M 5.24M 4.34M
Research & Development
16.83M 15.92M 15.79M 14.48M 17.14M 15.16M 14.64M 12.41M 13.68M 13.87M 15.14M 14.38M 15.69M 15.12M 20.12M 15.12M 13.71M 13.33M
Other Expenses
-28K 1K 5.81M -19K -17.18M n/a n/a n/a n/a -408K 5.81M -262K -207K -459K 6.78M -255K -256K -416K
Operating Expenses
20.69M 20.36M 19.75M 18.22M 21.65M 20.07M 18.34M 15.47M 17.05M 17.57M 18.7M 17.4M 19.86M 18.83M 22.79M 20.28M 18.69M 17.25M
Interest Expense
50K 54K 30K 33K 34K 36K 26K 26K 27K 97K n/a 77K 126K 154K 173K 181K 202K 26K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
20.69M 20.36M 19.75M 18.22M 21.65M 20.07M 18.34M 15.47M 17.05M 17.57M 18.7M 17.4M 19.86M 18.83M 22.79M 20.28M 18.69M 17.25M
Income Tax Expense
n/a n/a 3K n/a n/a 36K 1K 3K 3K 3K 2K 4K 3K 4K 3K n/a n/a 26K
Shares Outstanding (Basic)
100.63M 100.41M 110.06M 110.06M 99.55M 99.39M 86.74M 84.72M 84.61M 83.63M 83.59M 83.59M 84.46M 83.49M 72.89M 72.89M 72.72M 72.31M
Shares Outstanding (Diluted)
100.63M 100.41M 100.86M 100.86M 99.55M 99.39M 86.74M 84.72M 84.61M 83.63M 83.59M 83.59M 84.46M 83.49M 72.89M 72.89M 72.72M 72.31M
EPS (Basic)
-0.21 -0.19 -0.14 0.05 -0.23 -0.18 -0.05 -0.18 -0.2 -0.21 -0.22 -0.16 -0.23 -0.23 -0.29 -0.22 -0.26 -0.23
EPS (Diluted)
-0.21 -0.19 -0.15 0.05 -0.23 -0.18 -0.05 -0.18 -0.2 -0.21 -0.22 -0.16 -0.23 -0.23 -0.29 -0.22 -0.26 -0.23
EBITDA
-20.52M -18.36M -15.23M 6.07M -22.18M -18.88M -4.16M -14.56M -16.26M -16.84M -18.23M -12.86M -19.28M -18.23M -21.9M -15.1M -18.27M -16.7M
EBIT
-21.14M -18.98M -15.76M 5.54M -22.73M -17.83M -4.72M -15.11M -16.8M -17.41M -18.75M -13.44M -19.51M -18.69M -21.1M -15.74M -18.87M -16.71M
Depreciation & Amortization
623K 612K 529K 529K 548K 556K 555K 549K 541K 570K 605K 579K 575K 600K 628K 637K 593K 548K